Cytokinetics's total assets for Q3 2025 were $1.44B, an increase of 17.21% from the previous quarter. CYTK total liabilities were $1.96B for the fiscal quarter, a 22.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.